Search

everythinglearnresearchcommunity

for

Search:↓

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Psychotropic drugs can cause hair loss or excessive hair growth.

Extracts from three Polynesian plants were found to promote hair growth by affecting cell growth and gene expression related to hair.

Hydroxychloroquine can help treat certain types of hair loss.

Permanent hair dye may cause total hair loss.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Two children grew extra hair from taking omeprazole, which went away after they stopped the medication.

Combining ciclosporin and simvastatin can cause severe kidney damage.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Serum formulations were better at delivering molecules to the hair bulb than nanoparticles.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

A child with low platelets and anemia was later found to have lupus.

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The dog had sebaceous adenitis, treated with ciclosporin, leading to some hair regrowth.

Inositol and arginine solutions improve hair follicle health and turnover.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.